| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |